Updates

Date: August 5, 2026 BSE Limited, National Stock Exchange of India Limited, 20th Floor, P.J. Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai - 400001. Mumbai – 400 051 BSE Scrip Code: 544847 NSE Scrip Symbol: MANIPALHOS Subject: Intimation under Regulation 8(2) of the Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 Dear Sir/Ma’am, This is to inform you that, pursuant to Regulation 8(1) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 (“PIT Regulations”), Manipal Health Enterprises Limited (the “Company”) has framed a Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information. In accordance with Regulation 8(2) of the SEBI PIT Regulations the same is being submitted herewith. A copy of the said Code is enclosed herewith and has also been uploaded on the Company’s website. This intimation is being submitted for your information and records. You are requested to kindly take the same on record and disseminate it appropriately to all concerned. Thank you. For Manipal Health Enterprises Limited (formerly known as Manipal Health Enterprises Private Limited) Sathish K R Company Secretary and Compliance Officer Membership No.: A15203 Encl: a/a Manipal Health Enterprises Limited CODE OF PRACTICES AND PROCEDURES FOR FAIR DISCLOSURE OF UNPUBLISHED PRICE SENSITIVE INFORMATION I. INTRODUCTION In accordance with Regulation 8 read with Schedule A of the Securities and Exchange Board of India (“SEBI”) (Prohibition of Insider Trading) Regulations, 2015 (“PIT Regulations”), as amended, the Board of Manipal Health Enterprises Limited (“Company”), has adopted this ‘Code of practices and procedures for fair disclosure of Unpublished Price Sensitive Information’. II. OBJECTIVE The objective of the Code is to formulate a framework and policy for fair disclosure of events and occurrences that could impact price discovery in the market for the Company’s Securities, including the Unpublished Price Sensitive Information, and to maintain the uniformity, transparency and fairness in dealings with all stakeholders and ensure adherence to applicable laws and regulations. III. DEFINITIONS (i). “Board” shall mean the board of directors of the Company. (ii). “Code” means this Code of practices and procedures for fair disclosure of UPSI. (iii). “Company” shall mean Manipal Health Enterprises Limited (iv). “Compliance Officer” means Company Secretary or any senior officer, designated so and reporting to the Board, who is financially literate and is capable of appreciating requirements for legal and regulatory compliance under the PIT Regulations, and who shall be responsible for compliance of policies, procedures, maintenance of records, monitoring adherence to the rules of preservation of UPSI, monitoring of trades and the implementation of the codes specified under the PIT Regulations under the overall supervision of the Board. (v). “Connected Person” shall have the meaning given to such term in the PIT Regulations. (vi). “Designated Person” shall have the meaning given to such term in the PIT Regulations. (vii). “Insider” means any person who is:  a connected person; or  in possession of or having access to Unpublished Price Sensitive Information (viii). “Stock Exchange” shall mean a recognised stock exchange on which the securities of the Company are listed. (ix). “Unpublished Price Sensitive Information” or “UPSI” shall have the meaning given to such term in the PIT Regulations. All terms used but not defined herein shall have the meaning ascribed to such term under the PIT Regulations and the Code of Conduct for Prevention of Insider Trading of the Company formulated under Regulation 9 of the PIT Regulations (“Insider Code”). In case of any discrepancy between the PIT Regulations and the terms defined herein, the meaning as ascribed under the PIT Regulations, shall prevail. IV. CHIEF INVESTOR RELATIONS OFFICER (CIRO) 1.1 For the purposes of this Code, the person shall act as the Chief Investor Relations Officer (“CIRO”) as appointed by Managing Director/ Chief Executive Officer/ Chief Finance Officer from time to time. 1.2 The CIRO would be responsible for: (a) Ensuring uniform and universal dissemination of information and disclosure of UPSI at an appropriate time, to avoid selective disclosure; (b) Ensuring compliance with the Code and intimating instances of violations of the Code to the Compliance Officer; (c) Along with Compliance Officer, overseeing and monitoring sharing of information of the Company (including UPSI) by employees and educating employees on disclosure policies and procedures; (d) reviewing the disclosure process and controls and ensuring that same are operating effectively for compliance with the Code and the PIT Regulations; and (e) in discussion with the Board/ senior management, making an assessment of (i) materiality of information; (ii) updates, if any, required to be provided in respect of past disclosures; and (iii) the timing and adequacy of the proposed disclosures. 1.3 The CIRO shall strictly observe the timelines stipulated in terms of the SEBI regulatory framework with respect to prior intimations / notices / notifications and disclosures to ensure prompt disclosure of any UPSI that gets disclosed selectively / inadvertently. PURPOSE AND SCOPE 1.4 Prompt public disclosure of UPSI UPSI shall be disclosed to the Stock Exchanges by the CIRO or the Compliance Officer and disseminated promptly on a continuous basis as soon as credible and concrete information comes into being in order to make such information generally available. For the purposes of timely disclosures of UPSI and other material events, the Company shall follow the timelines as stipulated in the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 1.5 Uniform and Universal dissemination of UPSI to avoid selective disclosure The UPSI shall be disseminated uniformly and universally to all stakeholders through Stock Exchanges and by posting the same on official website of the Company. The Company shall use its best endeavors to avoid selective disclosure of UPSI. However, if any information gets disclosed selectively or inadvertently or otherwise, it should be brought to the notice of the CIRO, and such information shall be made generally available through dissemination of the same to Stock Exchanges and/or by posting the same on the official website of the Company as soon as practicable. 1.6 Procedures for responding to any queries on news reports and/or requests for verification of market rumors by regulatory authorities i. Appropriate, fair and prompt response shall be submitted to queries and/ or requests for verification of market rumors received from regulatory authorities or otherwise, in line with the applicable regulatory framework. ii. The CIRO shall, on receipt of requests as aforesaid, consult the CEO/ Whole-time Director/CFO and respond to the same without any delay. iii. Such replies shall be signed by the CIRO or in absence of CIRO, by the CFO or any other person as identified by the CIRO for the time being. iv. In case the query/request has been received from any Stock Exchange, a copy of such reply shall be sent to other stock exchange(s) also where equity shares of the Company are listed, if any, by the Compliance Officer. v. The CIRO alongwith Compliance Officer shall oversee all public disclosures by the Company. He/ she shall be responsible for deciding whether a public announcement is necessary for verifying or denying rumors and then making the appropriate disclosures in this regard. 1.7 Timely reporting of shareholdings / ownership and changes in ownership The Compliance Officer shall be responsible for ensuring that disclosures of shareholdings/ownership of major shareholders and disclosure of changes in ownership as required under the Regulations and / or any other rules/regulations made under the Securi [Showing first 8,000 characters — download PDF for full document]